★
Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads: coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

Guided View
New to markets (prices, yields, YTD, market cap)? We explain every term as you browse, in plain English. Same data, with the help built in.

Expert View
You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Manager record · ✦ curated · archived quarter

Glenview Capital

Larry Robbins (CEO) · New York, NY · CIK 1138995 · EDGAR filings ↗

Healthcare-heavy fundamental manager.

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Diff ⇄
$5.08BReported 13F value
48Positions
64.1%Top-10 weight
17.30Effective holdings
n/aEst. turnover
+0New
−0Exits

Reported 13F portfolio value covers U.S. reportable long positions only, not cash, bonds, shorts or non-U.S. holdings. It is not assets under management. No comparable prior filing; change columns unavailable this quarter.

Reported value by quarter Q2 2024 → Q2 2026
Sector exposure
Healthcare 58.8%
Technology 11.3%
Basic Materials 10.4%
Financial Services 6.8%
Industrials 4.6%
Consumer Cyclical 4.4%
Consumer Defensive 3.0%
Communication Services 0.7%

Share of reported common-equity value; (±pp) vs prior quarter.

The portfolio · Q2 2024
#SecurityWeightValueSharesΔ sharesHeld
1 THC Tenet Healthcare Corporation 13.1% $620.68M 4.67M n/a n/c 1
2 CVS CVS Health Corp. 11.5% $541.13M 9.16M n/a n/c 1
3 CI Cigna Corporation 9.1% $427.69M 1.29M n/a n/c 1
4 GPN Global Payments Inc. 6.4% $301.54M 3.12M n/a n/c 1
5 CTVA Corteva, Inc. 5.8% $273.61M 5.07M n/a n/c 1
6 ALIGHT INC (unmapped) n/a $227.72M 30.86M n/a n/a
7 UHS Universal Health Services… 4.6% $219.01M 1.18M n/a n/c 1
8 ESI Element Solutions Inc 3.6% $171.59M 6.33M n/a n/c 1
9 DXC DXC Technology Company 3.5% $166.21M 8.71M n/a n/c 1
10 MCK McKesson Corporation 3.3% $155.19M 265.72K n/a n/c 1
11 TEVA Teva Pharmaceutical… 3.2% $148.81M 9.16M n/a n/c 1
12 CLVT Clarivate Plc 3.1% $145.96M 25.65M n/a n/c 1
13 USFD US Foods Holding Corp. 2.8% $132.18M 2.49M n/a n/c 1
14 CNC Centene Corp. 2.0% $94.90M 1.43M n/a n/c 1
15 MYGN Myriad Genetics, Inc. 1.9% $91.69M 3.75M n/a n/c 1
16 UBER Uber Technologies, Inc. 1.8% $87.01M 1.20M n/a n/c 1
17 EXPE Expedia Group, Inc. 1.6% $75.52M 599.44K n/a n/c 1
18 KNX Knight-Swift Transportation… 1.5% $72.62M 1.45M n/a n/c 1
19 VTRS Viatris Inc. 1.5% $69.04M 6.49M n/a n/c 1
20 AMZN Amazon.com, Inc. 1.4% $67.72M 350.43K n/a n/c 1
21 HCA HCA Healthcare, Inc. 1.3% $62.84M 195.59K n/a n/c 1
22 WCC WESCO International, Inc. 1.3% $60.52M 381.77K n/a n/c 1
23 MRVL Marvell Technology, Inc. 1.3% $60.30M 862.67K n/a n/c 1
24 CAR Avis Budget Group, Inc. 1.2% $55.38M 529.83K n/a n/c 1
25 ELV Elevance Health Inc. 1.1% $53.42M 98.58K n/a n/c 1
26 BKD Brookdale Senior Living Inc. 1.0% $47.86M 7.01M n/a n/c 1
27 DNB DUN & BRADSTREET HLDGS INC 0.7% $33.43M 3.61M n/a n/c 1
28 BC Brunswick Corporation 0.7% $30.97M 425.63K n/a n/c 1
29 EXAS Exact Sciences Corporation 0.6% $26.59M 629.46K n/a n/c 1
30 TFX Teleflex Incorporated 0.5% $25.76M 122.48K n/a n/c 1
31 LYV Live Nation Entertainment… 0.5% $21.93M 233.90K n/a n/c 1
32 VVV Valvoline Inc. 0.4% $20.91M 484.01K n/a n/c 1
33 GTM ZoomInfo Technologies Inc. 0.4% $20.02M 1.57M n/a n/c 1
34 EVLV Evolv Technologies… 0.4% $16.70M 6.55M n/a n/c 1
35 OFIX ORTHOFIX MED INC 0.3% $14.65M 1.11M n/a n/c 1
36 CRS Carpenter Technology… 0.3% $14.25M 130.00K n/a n/c 1
37 LYFT Lyft, Inc. 0.2% $11.51M 816.45K n/a n/c 1
38 MTCH Match Group, Inc. 0.2% $10.76M 354.22K n/a n/c 1
39 BHC Bausch Health Companies Inc. 0.2% $9.11M 1.31M n/a n/c 1
40 DMRC DIGIMARC CORP NEW 0.2% $9.05M 291.86K n/a n/c 1
41 DNA Ginkgo Bioworks Holdings… 0.2% $8.86M 26.50M n/a n/c 1
42 FI Fiserv, Inc. 0.2% $8.01M 53.77K n/a n/c 1
43 BFLY Butterfly Network, Inc. 0.1% $6.79M 9.75M n/a n/c 1
44 RPID RAPID MICRO BIOSYSTEMS INC 0.0% $792,520 1.20M n/a n/c 1
45 DOMA DOMA HOLDINGS INC 0.0% $97,084 15.99K n/a n/c 1

Common-stock (SH) positions only; option lines are in the Options tab and are never netted. ✂ = change computed against split-adjusted prior shares. “Held N+” = held every quarter in our window, possibly longer.

Position age
440–1 quarters

Consecutive quarters each current position has been reported, within our data window.

Similar managers
ManagerCommon positionsName overlapWeighted similarity
Holocene Advisors, LP 24 3.0% 0.2532 Compare ⇄
Dodge & Cox 16 6.5% 0.2039 Compare ⇄
Appaloosa 4 6.3% 0.2021 Compare ⇄
Parnassus Investments, Llc 13 7.9% 0.1892 Compare ⇄
Point72 Asset Management 32 1.7% 0.1872 Compare ⇄
Grantham, Mayo, Van Otterloo & Co. LLC 21 3.1% 0.1843 Compare ⇄
Tiger Global Management 7 8.6% 0.1769 Compare ⇄
Boston Partners 26 3.2% 0.1752 Compare ⇄

Similarity of reported longs only; hedges and non-13F assets are invisible. Methodology

Filing record
Aug 14 2026 13F-HR · period Q2 2026

$5.49B · 45 holdings listed · View original SEC filing ↗

May 15 2026 13F-HR · period Q1 2026

$3.98B · 44 holdings listed · View original SEC filing ↗

Feb 17 2026 13F-HR · period Q4 2025

$4.91B · 57 holdings listed · View original SEC filing ↗

Nov 14 2025 13F-HR · period Q3 2025

$4.49B · 54 holdings listed · View original SEC filing ↗

Aug 14 2025 13F-HR · period Q2 2025

$3.57B · 43 holdings listed · View original SEC filing ↗

May 15 2025 13F-HR · period Q1 2025

$4.07B · 45 holdings listed · View original SEC filing ↗

Feb 14 2025 13F-HR · period Q4 2024

$3.96B · 36 holdings listed · View original SEC filing ↗

Nov 14 2024 13F-HR · period Q3 2024

$5.17B · 46 holdings listed · View original SEC filing ↗

Aug 14 2024 13F-HR · period Q2 2024

$5.08B · 48 holdings listed · View original SEC filing ↗

Provenance: All holdings parsed from this manager's 13F information tables on SEC EDGAR; values as reported, whole USD. Changes compare the latest accepted version of each quarter (amendments incorporated) on split-adjusted share counts. Reporting period: Q2 2024 · latest filing Aug 14, 2026 · Change methodology